Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
在市場風起雲湧和不確定時期，即使市場處於歷史最高點，許多投資者也會轉向股息率高的股票。這些公司通常具有高自由現金流並以高股息派息回報股東。
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Benzinga的讀者可以查看我們的分析師股票評級頁面，查看最新的分析師對他們最喜愛的股票的看法。交易員可以瀏覽Benzinga的廣泛分析師評級數據庫，包括按分析師準確性排序。
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
以下是醫療保健板塊三隻高收益股票最準確的分析師評級。
Royalty Pharma plc (NASDAQ:RPRX)
羅伊爾蒂製藥股份有限公司（NASDAQ：RPRX）
- Dividend Yield: 3.06%
- B of A Securities analyst Geoff Meacham maintained a Buy rating and cut the price target from $40 to $38 on April 12. This analyst has an accuracy rate of 64%.
- JP Morgan analyst Chris Schott maintained an Overweight rating and slashed the price target from $45 to $42 on Feb. 20. This analyst has an accuracy rate of 62%.
- Recent News: On June 3, Royalty Pharma priced offering of $1.5 billion of senior unsecured notes.
- Benzinga Pro's real-time newsfeed alerted to latest Royalty Pharma news
- 股息率：3.06%
- 4月12日，美銀證券分析師傑夫·米查姆（Geoff Meacham）維持買入評級，將目標價從40美元下調至38美元。該分析師的準確率爲64%。
- 2月20日，JP摩根分析師克里斯·肖特（Chris Schott）維持超配評級，將目標價從45美元下調至42美元。該分析師的準確率爲62%。
- 近期資訊：6月3日，羅伊爾蒂製藥定價15億美元的優先無抵押票據發行。
- Benzinga Pro的實時新聞提醒了最新的羅伊爾蒂製藥資訊。
Johnson & Johnson (NYSE:JNJ)
強生公司（紐交所股票代碼：JNJ）
- Dividend Yield: 3.38%
- Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating with a price target of $215 on May 6. This analyst has an accuracy rate of 68%.
- Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and cut the price target from $168 to $167 on April 17. This analyst has an accuracy rate of 70%.
- Recent News: Johnson & Johnson is scheduled to host a conference call for investors on Wednesday, July 17 to review second-quarter results.
- Benzinga Pro's charting tool helped identify the trend in Johnson & Johnson's stock.
- 股息率：3.38%
- 5月6日，康泰菲茲傑布·路易斯·陳（Louise Chen）分析師重申超配評級，目標價爲215美元。該分析師的準確率爲68%。
- 4月17日，摩根士丹利分析師特倫斯·弗林（Terence Flynn）維持等權評級，將目標價從168美元下調至167美元。該分析師的準確率爲70%。
- 近期資訊：強生公司定於7月17日星期三爲投資者舉行電話會議，審查第二季度業績。
- Benzinga Pro的圖表工具有助於識別強生股票的趨勢。
Medtronic plc (NYSE:MDT)
美敦力（MDT）公司（紐交所MDT）
- Dividend Yield: 3.42%
- Wells Fargo analyst Larry Biegelsen maintained an Overweight rating and increased the price target from $102 to $105 on May 24. This analyst has an accuracy rate of 71%.
- Truist Securities analyst Richard Newitter maintained a Hold rating and cut the price target from $90 to $88 on May 24. This analyst has an accuracy rate of 74%.
- Recent News: Medtronic, last week, initiated a recall for some versions of its StealthStation S8 application.
- Benzinga Pro's signals feature notified of a potential breakout in Medtronic's shares.
- 股息率：3.42%
- 5月24日，富國銀行分析師拉里·比格爾森（Larry Biegelsen）保持超配評級，並將目標價從102美元上調至105美元。該分析師的準確率爲71%。
- 5月24日，Truist Securities分析師理查德·紐維特（Richard Newitter）維持持有評級，並將目標價從90美元下調至88美元。該分析師的準確率爲74%。
- 近期資訊：上週美敦力公司啓動了對其StealthStation S8應用程序某些版本的召回。
- Benzinga Pro的信號特徵提示了美敦力股票可能出現突破。
譯文內容由第三人軟體翻譯。